Generating conditional mouse mutants via tetracycline-controlled gene expression.

[1]  G. Fishman,et al.  Conditional lineage ablation to model human diseases. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[2]  D. Tenen,et al.  Reversibility of acute B-cell leukaemia induced by BCR–ABL1 , 2000, Nature Genetics.

[3]  B. Conklin,et al.  Conditional expression and signaling of a specifically designed Gi-coupled receptor in transgenic mice , 1999, Nature Biotechnology.

[4]  H. Bujard,et al.  Tet repressor-based system for regulated gene expression in eukaryotic cells: principles and advances. , 2000, Methods in enzymology.

[5]  R. Cortese,et al.  Stringent control of gene expression in vivo by using novel doxycycline-dependent trans-activators. , 2002, Human gene therapy.

[6]  Studies on Conditional Gene Expression in the Brain , 1999, Annals of the New York Academy of Sciences.

[7]  Eric R. Kandel,et al.  Inducible and Reversible Enhancement of Learning, Memory, and Long-Term Potentiation by Genetic Inhibition of Calcineurin , 2001, Cell.

[8]  R. Flavell,et al.  Regulated overexpression of interleukin 11 in the lung. Use to dissociate development-dependent and -independent phenotypes. , 1997, The Journal of clinical investigation.

[9]  Andrey Rzhetsky,et al.  A Chemosensory Gene Family Encoding Candidate Gustatory and Olfactory Receptors in Drosophila , 2001, Cell.

[10]  M. Gossen,et al.  Co-regulation of two gene activities by tetracycline via a bidirectional promoter. , 1995, Nucleic acids research.

[11]  J. Mallet,et al.  A single adenovirus vector mediates doxycycline-controlled expression of tyrosine hydroxylase in brain grafts of human neural progenitors , 1999, Nature Biotechnology.

[12]  M. Gossen,et al.  Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[13]  René Hen,et al.  Decreased nuclear β‐catenin, tau hyperphosphorylation and neurodegeneration in GSK‐3β conditional transgenic mice , 2001 .

[14]  D. Kioussis,et al.  Inducible expression of a p56Lck transgene reveals a central role for Lck in the differentiation of CD4 SP thymocytes. , 2000, Immunity.

[15]  W. Hillen,et al.  Mechanisms underlying expression of Tn10 encoded tetracycline resistance. , 1994, Annual review of microbiology.

[16]  J. Vilotte,et al.  Use of doxycycline-controlled gene expression to reversibly alter milk-protein composition in transgenic mice. , 2001, European journal of biochemistry.

[17]  E. Kandel,et al.  Inducible and Reversible Gene Expression with the rtTA System for the Study of Memory , 1998, Neuron.

[18]  C Benoist,et al.  Tetracycline-controllable selection of CD4(+) T cells: half-life and survival signals in the absence of major histocompatibility complex class II molecules. , 2000, The Journal of experimental medicine.

[19]  M. Wilkinson,et al.  The stability and fate of a spliced intron from vertebrate cells. , 1999, RNA.

[20]  J. Chamberlain,et al.  Mdx mice inducibly expressing dystrophin provide insights into the potential of gene therapy for duchenne muscular dystrophy. , 2000, Human molecular genetics.

[21]  M. L. Kaplan,et al.  Tetracycline-regulated cardiac gene expression in vivo. , 1994, The Journal of clinical investigation.

[22]  David K. Stevenson,et al.  Bioluminescent indicators in living mammals , 1998, Nature Medicine.

[23]  S. Prusiner,et al.  Doxycycline control of prion protein transgene expression modulates prion disease in mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[24]  M. Gossen,et al.  Tetracyclines in the control of gene expression in eukaryotes , 2001 .

[25]  L. Tsui,et al.  Regulated expression of the human CFTR gene in epithelial cells. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[26]  M. Gossen,et al.  Use of tetracycline-controlled gene expression systems to study mammalian cell cycle. , 1997, Methods in enzymology.

[27]  S. Tilghman,et al.  The temporal requirement for endothelin receptor-B signalling during neural crest development , 1999, Nature.

[28]  M. Gossen,et al.  Transcriptional activation by tetracyclines in mammalian cells. , 1995, Science.

[29]  Eric R Kandel,et al.  Restricted and Regulated Overexpression Reveals Calcineurin as a Key Component in the Transition from Short-Term to Long-Term Memory , 1998, Cell.

[30]  G. Fishman,et al.  Regulated expression of foreign genes in vivo after germline transfer. , 1994, The Journal of clinical investigation.

[31]  G. Fishman,et al.  Expression of protein kinase C beta in the heart causes hypertrophy in adult mice and sudden death in neonates. , 1997, The Journal of clinical investigation.

[32]  A. Poole,et al.  Postnatal expression in hyaline cartilage of constitutively active human collagenase-3 (MMP-13) induces osteoarthritis in mice. , 2001, The Journal of clinical investigation.

[33]  Hermann Bujard,et al.  Tetracycline-regulated gene expression in the brain , 2000, Current Opinion in Neurobiology.

[34]  E. Kandel,et al.  Control of Memory Formation Through Regulated Expression of a CaMKII Transgene , 1996, Science.

[35]  M. T. Hasan,et al.  Exploring the sequence space for tetracycline-dependent transcriptional activators: novel mutations yield expanded range and sensitivity. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[36]  C. Benoist,et al.  Role of the forkhead transcription family member, FKHR, in thymocyte differentiation , 2000, European journal of immunology.

[37]  H. Bujard,et al.  The B Lymphocyte-Specific Coactivator BOB.1/OBF.1 Is Required at Multiple Stages of B-Cell Development , 2001, Molecular and Cellular Biology.

[38]  W. Lee,et al.  The retinoblastoma gene regulates somatic growth during mouse development. , 2001, Cancer research.

[39]  J. Tichelaar,et al.  FGF-10 disrupts lung morphogenesis and causes pulmonary adenomas in vivo. , 2001, American journal of physiology. Lung cellular and molecular physiology.

[40]  L. Hennighausen,et al.  Conditional gene expression in secretory tissues and skin of transgenic mice using the MMTV‐LTR and the tetracycline responsive system , 1995, Journal of Cellular Biochemistry.

[41]  M. Gossen,et al.  Tetracycline-controlled transcription in eukaryotes: novel transactivators with graded transactivation potential. , 1997, Nucleic acids research.

[42]  A. Glick,et al.  Conditional gene expression in the epidermis of transgenic mice using the tetracycline-regulated transactivators tTA and rTA linked to the keratin 5 promoter. , 2000, The Journal of investigative dermatology.

[43]  R. Homer,et al.  Use of the Tetracycline-controlled Transcriptional Silencer (tTS) to Eliminate Transgene Leak in Inducible Overexpression Transgenic Mice* , 2001, The Journal of Biological Chemistry.

[44]  René Hen,et al.  Reversal of Neuropathology and Motor Dysfunction in a Conditional Model of Huntington's Disease , 2000, Cell.

[45]  J. Tichelaar,et al.  Conditional Expression of Fibroblast Growth Factor-7 in the Developing and Mature Lung* , 2000, The Journal of Biological Chemistry.

[46]  D. Bohl,et al.  Long-term control of erythropoietin secretion by doxycycline in mice transplanted with engineered primary myoblasts , 1997, Nature Medicine.

[47]  M. Kelz,et al.  Transgenic animals with inducible, targeted gene expression in brain. , 1998, Molecular pharmacology.

[48]  J. Perea,et al.  Induced myelination and demyelination in a conditional mouse model of Charcot-Marie-Tooth disease type 1A. , 2001, Human molecular genetics.

[49]  D. Surmeier,et al.  Expression of the transcription factor ΔFosB in the brain controls sensitivity to cocaine , 1999, Nature.

[50]  D. Felsher,et al.  Reversible tumorigenesis by MYC in hematopoietic lineages. , 1999, Molecular cell.

[51]  Mark Ptashne,et al.  Negative effect of the transcriptional activator GAL4 , 1988, Nature.

[52]  S. Efrat,et al.  Conditional transformation of a pancreatic beta-cell line derived from transgenic mice expressing a tetracycline-regulated oncogene. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[53]  R. Sarao,et al.  Conditional Transgene Expression in Endothelial Cells , 1998, Transgenic Research.

[54]  M. Husain,et al.  Conditional and targeted overexpression of vascular chymase causes hypertension in transgenic mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[55]  A. P. Soler,et al.  Conversion of C57Bl/6 mice from a tumor promotion–resistant to a –sensitive phenotype by enhanced ornithine decarboxylase expression , 1999, Molecular carcinogenesis.

[56]  T. Liang,et al.  Conditional Liver-specific Expression of Simian Virus 40 T Antigen Leads to Regulatable Development of Hepatic Neoplasm in Transgenic Mice* , 2001, The Journal of Biological Chemistry.

[57]  U. Schibler,et al.  The 5' flanking region of the rat LAP (C/EBP beta) gene can direct high-level, position-independent, copy number-dependent expression in multiple tissues in transgenic mice. , 1994, Nucleic acids research.

[58]  M. Mayford,et al.  A GFP-equipped bidirectional expression module well suited for monitoring tetracycline-regulated gene expression in mouse. , 2001, Nucleic acids research.